GINO SANTINI Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for GINO SANTINI.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of GINO SANTINI. GINO SANTINI is a Director in AMAG PHARMACEUTICALS INC. ($AVM) and a President, US Operations in LILLY ELI & CO ($LLY) and a Sr.VP, Corp. Strategy & BD in LILLY ELI & CO ($LLY) and a Sr.VP, Corp. Strategy & Policy in LILLY ELI & CO ($LLY) and a Director in Vitae Pharmaceuticals, Inc ($VTAE) and a Director in COLLEGIUM PHARMACEUTICAL, INC ($COLL) and a Director in INTERCEPT PHARMACEUTICALS INC ($ICPT) and a Director in Horizon Pharma plc ($HZNP) and a Director in Allena Pharmaceuticals, Inc. ($ALNA).

Over the past year GINO SANTINI has been an insider in 5 companies. The total value of shares held by GINO SANTINI in these companies amounts to $1,900,194.

GINO SANTINI Director
Allena Pharmaceuticals, Inc.
Director
AMAG PHARMACEUTICALS, INC.
Director
COLLEGIUM PHARMACEUTICAL, INC
Director
Horizon Therapeutics Public Ltd Co
Director
INTERCEPT PHARMACEUTICALS, INC.
Sr.VP, Corp. Strategy & BD, Sr.VP, Corp. Strategy & Policy, President, US Operations
LILLY ELI & CO
Director
Vitae Pharmaceuticals, Inc
$ 1900194 The total value of shares held by GINO SANTINI
Insider Rank

GINO SANTINI ranks 11,903 out of 350,000 insiders. Go to Insider Ranking to see more.

Address: LILLY CORPORATE CENTER INDIANAPOLIS 46285 IN

Companies in which GINO SANTINI is an Insider

Allena Pharmaceuticals, Inc.

Trading Symbol: ALNA
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of GINO SANTINI: Director
Holdings: 0 shares
Latest Transaction: Jun 07 2019

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

AMAG PHARMACEUTICALS, INC.

Trading Symbol: AVM
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GINO SANTINI: Director
Holdings: 31,204 shares
Latest Transaction: May 20 2019

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 4x
Sell: 0x
Shares Bought: 21,007
Shares Sold: 0
Share Difference: +21,007
Value Difference: $0

COLLEGIUM PHARMACEUTICAL, INC

Trading Symbol: COLL
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GINO SANTINI: Director
Holdings: 30,148 shares
Current Value: $463,073
Latest Transaction: Apr 29 2019
$COLL Market Capitalization: $351.67M
$COLL Previous Close: $15.36

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 2x
Sell: 0x
Shares Bought: 6,960
Shares Sold: 0
Share Difference: +6,960
Value Difference: $0

Horizon Therapeutics Public Ltd Co

Trading Symbol: HZNP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GINO SANTINI: Director
Holdings: 36,173 shares
Current Value: $609,877
Latest Transaction: May 06 2019
$HZNP Market Capitalization: $2.68B
$HZNP Previous Close: $16.86

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 4x
Sell: 4x
Shares Bought: 48,585
Shares Sold: 18,426
Share Difference: +30,159
Value Difference: +$337,960

INTERCEPT PHARMACEUTICALS, INC.

Trading Symbol: ICPT
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GINO SANTINI: Director
Holdings: 7,284 shares
Current Value: $827,244
Latest Transaction: Jun 21 2019
$ICPT Market Capitalization: $2.80B
$ICPT Previous Close: $113.57

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 4x
Sell: 0x
Shares Bought: 5,984
Shares Sold: 0
Share Difference: +5,984
Value Difference: $0

LILLY ELI & CO

Trading Symbol: LLY
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GINO SANTINI: Sr.VP, Corp. Strategy & BD, Sr.VP, Corp. Strategy & Policy, President, US Operations
Holdings: 102,174 shares
Current Value: $7,938,920
Latest Transaction: Feb 03 2009
$LLY Market Capitalization: $83.74B
$LLY Previous Close: $77.70

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Vitae Pharmaceuticals, Inc

Trading Symbol: VTAE
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GINO SANTINI: Director
Holdings: 0 shares
Latest Transaction: Oct 25 2016

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of GINO SANTINI

Sentiment: All, ALNA, AVM, COLL, HZNP, ICPT, LLY, VTAE

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 21 2019ICPTINTERCEPT PHARMACE ...SANTINI GINODirectorOption ExerciseA82.252,174178,8122,174
Jun 21 2019ICPTINTERCEPT PHARMACE ...SANTINI GINODirectorGrantA0.001,57007,2845.7 K to 7.3 K (+27.48 %)
Jun 07 2019ALNAAllena Pharmaceuti ...SANTINI GINODirectorOption ExerciseA5.5914,00078,26014,000
May 20 2019AVMAMAG PHARMACEUTICA ...SANTINI GINODirectorOption ExerciseA10.7817,326186,77417,326
May 20 2019AVMAMAG PHARMACEUTICA ...SANTINI GINODirectorGrantA0.008,116031,20423.1 K to 31.2 K (+35.15 %)
May 06 2019HZNPHorizon Therapeuti ...SANTINI GINODirectorOption ExerciseM0.0015,32000
May 06 2019HZNPHorizon Therapeuti ...SANTINI GINODirectorOption ExerciseA0.0015,390015,390

View all GINO SANTINI insider transactions.

What Do the Transaction Codes Mean?

Each transaction listed on the Form 4 filing must be marked with a transaction code. Here is a list and description of transaction codes as used and categorized by the SEC. More ...

What Is a Rule 10b5-1 Plan?

Rule 10b5 is one of the most important acts put forth by the SEC. It prohibits fraud, misrepresentation, and deceit in the sale and purchase of securities on national exchanges. More ...

What Should I Do When Insiders Are Selling Stock?

It's often said that insider selling can be a hint that they know that their stock is about to underperform the market. Even though this is true in some cases, it's also true that insider selling is frequently simply behind financial reasons of the insiders and have no connection with the company's prospects. More ...

Contact us | Follow us on Twitter